Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Safotibant (Alias: LF22-0542, LF-22-0542, LF-220542, LF220542, LF 22-0542, LF 220542)

Catalog No. T34485 Copy Product Info
Purity: 99.67%
🥰Excellent
Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.

Safotibant

Copy Product Info
🥰Excellent
Catalog No. T34485
Alias LF22-0542, LF-22-0542, LF-220542, LF220542, LF 22-0542, LF 220542

Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.

Safotibant
Cas No. 633698-99-4
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$88In StockIn Stock
5 mg$210In StockIn Stock
10 mg$318In StockIn Stock
25 mg$515-In Stock
50 mg$708-In Stock
100 mg$953-In Stock
200 mg$1,280-In Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.67%
Appearance:Oil
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
In vivo
LF22-0542 (1% in saline; eye drop; twice a day for 7 days; diabetic rats) significantly reduced Retinal plasma extravasation, leukostasis, and mRNA levels of B(1)R, iNOS, COX-2, VEGF receptor type 2, IL-1β and HIF-1α to the control value level.[1]
SynonymsLF22-0542, LF-22-0542, LF-220542, LF220542, LF 22-0542, LF 220542
Chemical Properties
Molecular Weight502.63
FormulaC25H34N4O5S
Cas No.633698-99-4
SmilesS(N(CCOCC(N(CC1=CC=C(C=C1)C=2NCCN2)C)=O)C)(=O)(=O)C3=C(C)C=C(OC)C=C3C
Relative Density.1.23 g/cm3 (Predicted)
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (99.48 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9895 mL9.9477 mL19.8954 mL99.4768 mL
5 mM0.3979 mL1.9895 mL3.9791 mL19.8954 mL
10 mM0.1990 mL0.9948 mL1.9895 mL9.9477 mL
20 mM0.0995 mL0.4974 mL0.9948 mL4.9738 mL
50 mM0.0398 mL0.1990 mL0.3979 mL1.9895 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Safotibant | purchase Safotibant | Safotibant cost | order Safotibant | Safotibant chemical structure | Safotibant in vivo | Safotibant formula | Safotibant molecular weight